Recent Articles

May 17, 2016 8:45 am
Dr. Chase Spurlock, IQuity CEO and Dr. Thomas Aune, IQuity Chief Science Officer
Diagnosing complex autoimmune diseases and related conditions is a challenging endeavor, as these multifaceted conditions often present with non-specific symptoms across several organ systems. However, emerging RNA-based diagnostic technologies can dramatically reduce the time to diagnosis of complex diseases, including autoimmune disease.
May 16, 2016 10:16 am
Ryan Bushey, Digital Editor
Alex Gorsky discussed everything from developing new drugs to establishing an appropriate pricing system for these medications.
May 14, 2016 10:30 am
Rebecca Robbins, MPharmacol, Neurology and Opthamology Analyst, GlobalData
The scope for improvement in the Huntington’s disease space is vast. 
May 13, 2016 1:31 pm
Ryan Bushey, Digital Editor
The acquisition is expected to close by the end of the third quarter.
May 11, 2016 4:10 pm
Ryan Bushey, Digital Editor
Details surrounding this venture are vague.
May 11, 2016 8:29 am
Rachel Jonas, UCLA, The Conversation
To find out, researchers are trying to fill in the blanks between the genetic blueprint (genotype) and psychiatric disorder (psychiatric phenotype)
May 10, 2016 1:31 pm
Alexandra Annis, MSc, Immunology Analyst, GlobalData
The recommended dosing for Taltz is an initial 160 milligrams (mg) subcutaneous (SC) injection.
May 10, 2016 10:30 am
Ryan Bushey, Digital Editor
The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.
May 9, 2016 10:18 am
Geert Cauwenbergh, Dr. Med. Sc, President and CEO of RXi Pharmaceuticals Corporation
The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics. 
May 6, 2016 3:08 pm
Ryan Bushey, Digital Editor
Over 4,000 type 2 diabetes patients took part in this placebo-controlled global study over the course of three years.
Subscribe to Drug Discovery & Development